---
figid: PMC9026123__toxics-10-00151-g001
pmcid: PMC9026123
image_filename: toxics-10-00151-g001.jpg
figure_link: /pmc/articles/PMC9026123/figure/toxics-10-00151-f001/
number: Figure 1
figure_title: ''
caption: 'Scheme of the thiopurine biotransformation pathway. Explanation of abbreviations:
  AZA—azathioprine; GST—glutathione S-transferase; 6MP—6-mercaptopurine; XOD—xanthine
  oxidase/dehydrogenase; 6TUA—6-thiouric acid; TPMT—thiopurine methyltransferase;
  6MMP—6-methylmercaptopurine; HPRT—hypoxanthine phosphoribosyltransferase; 6TIMP—6-thioinosine
  monophosphate; IMPDH—inosine monophosphate dehydrogenase; 6MMPR—6-methylmercaptopurine
  ribonucleotide; GMPS—guanosine monophosphate synthetase; 6TGN—6-thioguanine nucleotides;
  6TGMP—6-thioguanosine monophosphate; 6TGDP—6-thio-guanosine diphosphate; 6TdGMP—6-thio-deoxyguanosine
  monophosphate; 6TdGDP—6-thiodeoxyguanosine diphosphate; 6TdGTP—6-thio-deoxyguanosine
  triphosphate; 6TGTP—6-thioguanosine triphosphate; NUDT15—nudix hydrolase motif 15.'
article_title: Cytotoxicity of Thiopurine Drugs in Patients with Inflammatory Bowel
  Disease.
citation: Oliwia Zakerska-Banaszak, et al. Toxics. 2022 Apr;10(4):151.
year: '2022'

doi: 10.3390/toxics10040151
journal_title: Toxics
journal_nlm_ta: Toxics
publisher_name: MDPI

keywords:
- thiopurines
- azathioprine
- mercaptopurine
- thioguanine
- cytotoxicity
- inflammatory bowel disease
- Crohn’s disease
- ulcerative colitis
- pharmacogenetics
- therapeutic drug monitoring

---
